These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11257053)

  • 1. Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trials.
    Wallis RS; Phillips M; Johnson JL; Teixeira L; Rocha LM; Maciel E; Rose L; Wells C; Palaci M; Dietze R; Eisenach K; Ellner JJ
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1302-4. PubMed ID: 11257053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis.
    Dietze R; Teixeira L; Rocha LM; Palaci M; Johnson JL; Wells C; Rose L; Eisenach K; Ellner JJ
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1972-6. PubMed ID: 11408210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR.
    Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of individual drugs in the chemotherapy of tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
    Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.
    Yamamoto T; Amitani R; Suzuki K; Tanaka E; Murayama T; Kuze F
    Antimicrob Agents Chemother; 1996 Feb; 40(2):426-8. PubMed ID: 8834891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of rifalazil in a combination treatment regimen as an alternative to isoniazid-rifampin therapy in a mouse tuberculosis model.
    Lenaerts AM; Chase SE; Cynamon MH
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3167-8. PubMed ID: 11036043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell monitoring of chemotherapy in experimental rat tuberculosis.
    Foo DG; Tay HC; Siew JY; Singhal A; Camacho L; Bifani P; Dartois V; Hervé M
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3677-83. PubMed ID: 21628535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular medicine and treatment of tuberculosis].
    Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
    Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2004 Dec; 2(28):83-8. PubMed ID: 15557876
    [No Abstract]   [Full Text] [Related]  

  • 13. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.
    Mitchison DA
    Soc Appl Bacteriol Symp Ser; 1996; 25():72S-80S. PubMed ID: 8972122
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
    Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Genotype MTBDR assay directly on sputum specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    Int J Tuberc Lung Dis; 2006 Sep; 10(9):1057-9. PubMed ID: 16964801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of tuberculosis among contacts of isoniazid-resistant and isoniazid-susceptible cases.
    Tuberculosis Research Centre, Indian Council of Medical Research (ICMR), Chennai, India
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):782-8. PubMed ID: 21575299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.
    Lounis N; Bentoucha A; Truffot-Pernot C; Ji B; O'Brien RJ; Vernon A; Roscigno G; Grosset J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3482-6. PubMed ID: 11709328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia.
    Shamputa IC; Jugheli L; Sadradze N; Willery E; Portaels F; Supply P; Rigouts L
    Respir Res; 2006 Jul; 7(1):99. PubMed ID: 16846493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin.
    Somoskovi A; Dormandy J; Mitsani D; Rivenburg J; Salfinger M
    J Clin Microbiol; 2006 Dec; 44(12):4459-63. PubMed ID: 17035488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis.
    Garbe TR; Hibler NS; Deretic V
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1754-6. PubMed ID: 8807080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.